Dodt, 1995 - Google Patents
Anticoagulatory substances of bloodsucking animals: from hirudin to hirudin mimeticsDodt, 1995
- Document ID
- 5076740416772302453
- Author
- Dodt J
- Publication year
- Publication venue
- Angewandte Chemie International Edition in English
External Links
Snippet
Bloodsucking animals contain substances in their saliva that specifically interfere with the blood clotting system. These substances are mainly low molecular weight proteins with a molecular mass of between 4 and 50 kDa. Some have become accessible in large …
- 101700042506 HIRUD 0 title abstract description 120
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8121—Serpins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/75—Fibrinogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
- C07K5/06095—Arg-amino acid
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5514409A (en) | Methods for coating invasive devices with inhibitors of thrombin | |
| Tapparelli et al. | Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profile | |
| US5433940A (en) | Inhibitors of thrombin | |
| EP0333356A2 (en) | Hirudin peptides | |
| EP0815139B1 (en) | Thrombin inhibitors based on the amino acid sequence of hirudin | |
| CN102026652A (en) | Thrombin inhibitor | |
| JPH11511963A (en) | Kunitz-type plasma kallikrein inhibitor | |
| Johnson et al. | Biochemistry and genetic engineering of hirudin | |
| WO1990003391A1 (en) | Hirudin peptides | |
| Bichler et al. | Hirudin, a new therapeutic tool? | |
| CA2101614A1 (en) | Synthetic peptides derived from vitronectin and pharmaceutical compositions comprising them | |
| Dodt | Anticoagulatory substances of bloodsucking animals: from hirudin to hirudin mimetics | |
| CA2175388A1 (en) | Bivalent thrombin inhibitors | |
| Schapira et al. | Protection by recombinant alpha 1-antitrypsin Ala357 Arg358 against arterial hypotension induced by factor XII fragment. | |
| Markwardt | Hirudin: the famous anticoagulant agent | |
| Wallis | Patent Update: Inhibitors of Coagulation Factor Xa: From Macromolecular Beginnings to Small Molecules | |
| Iyer et al. | Leading Article: Cardiovascular & Renal: Recombinant hirudin: A perspective | |
| Callas et al. | Fibrinolytic compromise by synthetic and recombinant thrombin inhibitors: implications in the treatment of thrombotic disorders | |
| Scharfstein et al. | Molecular approaches to antithrombotic therapy | |
| DiMaio et al. | Thrombin inhibitors and thrombin receptor agonists/antagonists | |
| Cappiello et al. | Hirunorms, novel hirudin-like direct thrombin inhibitors | |
| WO1996030407A1 (en) | Bifunctional thrombin inhibitors bearing highly truncated fibrinogen recognition exosite binding component | |
| Markwardt | Institute of Pharmacology and Toxicology, Medical Academy Erfurt, Erfurt, Federal Republic of Germany | |
| Di Maio | Hirudin and hirudin fragments form the basis of new antithrombotics and anticoagulants | |
| JP2001519442A (en) | Trivalent thrombin inhibitors |